These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10766136)

  • 21. Causes, outcomes, and owner satisfaction of dogs undergoing enucleation with orbital implant placement.
    Palmer SV; Velloso Ramos R; Woodoff-Leith ED; Rodriguez Galarza RM
    Vet Ophthalmol; 2021 Jul; 24(4):346-353. PubMed ID: 33955641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular rehabilitation following socket reconstruction with amniotic membrane transplantation with failed primary hydroxyapatite implant post enucleation.
    Aggarwal H; Kumar P; Singh RD; Chand P; Alvi HA
    Cont Lens Anterior Eye; 2015 Feb; 38(1):64-9. PubMed ID: 25282000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the exposure rate of wrapped hydroxyapatite (Bio-Eye) versus unwrapped porous polyethylene (Medpor) orbital implants in enucleated patients.
    Tabatabaee Z; Mazloumi M; Rajabi MT; Khalilzadeh O; Kassaee A; Moghimi S; Eftekhar H; Goldberg RA
    Ophthalmic Plast Reconstr Surg; 2011; 27(2):114-8. PubMed ID: 20829725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term complications of different porous orbital implants: a 21-year review.
    Lin CW; Liao SL
    Br J Ophthalmol; 2017 May; 101(5):681-685. PubMed ID: 27474155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Complications of hydroxyapatite orbital implants in children: a series of 105 cases].
    Lumbroso L; Levy C; Plancher C; Validire P; Asselain B; Doz F; Schlienger P; Desjardins L
    J Fr Ophtalmol; 2000 Mar; 23(3):249-54. PubMed ID: 10740051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complications of primary placement of motility post in porous polyethylene implants during enucleation.
    Yazici B; Akova B; Sanli O
    Am J Ophthalmol; 2007 May; 143(5):828-834. PubMed ID: 17362860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of implant extrusion rates and postoperative pain after evisceration with immediate or delayed implants and after enucleation with implants.
    Liu D
    Trans Am Ophthalmol Soc; 2005; 103():568-91. PubMed ID: 17057818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of complications of the hydroxyapatite orbital implant in 250 consecutive cases.
    Shields CL; Shields JA; De Potter P; Singh AD
    Trans Am Ophthalmol Soc; 1993; 91():177-89; discussion 189-95. PubMed ID: 8140690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of the hydroxyapatite ocular implant in the pediatric population.
    De Potter P; Shields CL; Shields JA; Singh AD
    Arch Ophthalmol; 1994 Feb; 112(2):208-12. PubMed ID: 8311774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of unwrapped spherical orbital implants.
    Perry JD; Tam RC
    Ophthalmic Plast Reconstr Surg; 2004 Jul; 20(4):281-4. PubMed ID: 15266141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long term follow up of bone derived hydroxyapatite orbital implants.
    Suter AJ; Molteno AC; Bevin TH; Fulton JD; Herbison P
    Br J Ophthalmol; 2002 Nov; 86(11):1287-92. PubMed ID: 12386091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Porous orbital implants, wraps, and PEG placement in the pediatric population after enucleation.
    Wang JK; Liao SL; Lin LL; Kao SC; Tseng HS
    Am J Ophthalmol; 2007 Jul; 144(1):109-116. PubMed ID: 17499206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complications of sclera-covered enucleation implants.
    Custer PL; McCaffery S
    Ophthalmic Plast Reconstr Surg; 2006; 22(4):269-73. PubMed ID: 16855498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxyapatite orbital implant after enucleation--experience with 200 cases.
    Shields JA; Shields CL; De Potter P
    Mayo Clin Proc; 1993 Dec; 68(12):1191-5. PubMed ID: 8246621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anophthalmic cavity and implant extrusion].
    Schellini SA; Ichida FK; Padovani CR
    Arq Bras Oftalmol; 2007; 70(5):752-5. PubMed ID: 18157296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Culture-proven Aspergillus fumigatus infection in a primary hydroxyapatite orbital implant.
    Sharma NS; Ooi JL; Maloof TC; Wilcsek G; Francis IC; Coroneo MT
    Clin Exp Ophthalmol; 2007 Apr; 35(3):294-5. PubMed ID: 17430526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orbital implants in enucleation surgery: a report by the American Academy of Ophthalmology.
    Custer PL; Kennedy RH; Woog JJ; Kaltreider SA; Meyer DR
    Ophthalmology; 2003 Oct; 110(10):2054-61. PubMed ID: 14522788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exposure rate of smooth surface tunnel porous polyethylene implants after enucleation.
    Mahoney NR; Grant MP; Iliff NT; Merbs SL
    Ophthalmic Plast Reconstr Surg; 2014; 30(6):492-8. PubMed ID: 25369179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scleral wrap increases the long-term complication risk of bone-derived hydroxyapatite orbital implants.
    Toh T; Bevin TH; Molteno AC
    Clin Exp Ophthalmol; 2008 Nov; 36(8):756-61. PubMed ID: 19128381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of results of enucleations with orbital implant in children and adolescents].
    Hautz W; Grałek M; Karczmarewicz B; Kanigowska K; Klimczak-Slaczka D; Chipczyńska B
    Klin Oczna; 2006; 108(7-9):312-5. PubMed ID: 17290831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.